The ISLET Act, also known as Bill 118 hr 4304, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to provide funding and support for research into the treatment and potential cure for type 1 diabetes.
The ISLET Act aims to allocate resources towards the study of islet cell transplantation, a promising treatment for type 1 diabetes. Islet cells are responsible for producing insulin in the body, and transplanting healthy islet cells into individuals with type 1 diabetes can help regulate their blood sugar levels.
The bill proposes funding for research institutions and medical centers to further study islet cell transplantation and its effectiveness in treating type 1 diabetes. It also calls for the establishment of a national registry to track outcomes of islet cell transplants and improve patient care.
Overall, the ISLET Act seeks to advance research and innovation in the field of diabetes treatment, with the ultimate goal of improving the quality of life for individuals living with type 1 diabetes.